InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Mack Anthony P., Chairman & CEO. Officer active across 1 company, notably Virpax Pharmaceuticals, Inc.. Cumulatively, 3 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €274k. History available since 18 November 2021. The latest transaction was filed on 18 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
75,750 shares@ US$1.343.15% mcap35.4% of flowCommon Stock, $0.00001 par valueSEC:0001493152-22-014659:0
Ideal exit: 12 Feb 2023 (T+270)
25,125 shares@ US$3.99100.0% of flowCommon Stock, $0.00001 par valueSEC:0000905718-21-001521
Ideal exit: 15 Aug 2022 (T+270)
25,125 shares@ US$3.992.88% mcap32.3% of flowCommon Stock, $0.00001 par valueSEC:0000905718-21-001521:0
Ideal exit: 15 Aug 2022 (T+270)
3 of 3 declarations
About Mack Anthony P.
Mack Anthony P. is the President and CEO of Virpax Pharmaceuticals, Inc. He oversees the company's operations and leads strategic initiatives to develop innovative treatments in the pharmaceutical sector.
